Postglucose growth hormone nadir and insulin-like growth factor-1 in naïve-active acromegalic patients Do these parameters always correlate?;Nadir do hormônio de crescimento após glicose e fator de crescimento insulina-símile do tipo 1 em pacientes acromegálicos ativos virgens de tratamento: São estes parâmetros sempre correlacionáveis?

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 55, Issue 7, 2011, Pages 494-497

  Antônio Jr , Ribeiro Oliveira ^a   Faje, Alex ^b   Barkan, Ariel ^b,c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82955189748     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302011000700011     Document Type: Letter

References (16)

1. Duncan E, Wass JA. Investigation protocol: acromegaly and its investigation. Clin Endocrinol (Oxf). 1999;50(3):285-93.
2. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, et al. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab. 2010;95(7):3141-8.
3. Vieira Neto L, Abuchan J, Araujo LA, Boguszewski CL, Bronstein MD, Czepielewski M, et al. Recomendações do Departamento de Neuroendocrinologia da Sociedade Brasileira de Endocrinologia e Metabologia para o diagnóstico e tratamento da acromegalia no Brasil. Arq Bras Endocrinol Metab. 2011;55(2):91-105.
4. Ribeiro-Oliveira A Jr, Faje AT, Barkan AL. Limited utility of oral glucose tolerance test in biochemically active acromegaly. Eur J Endocrinol. 2011;164(1):17-22.
5. Arafat AM, Möhlig M, Weickert MO, Perschel FH, Purschwitz J, Spranger J, et al. Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J Clin Endocrinol Metab. 2008;93(4):1254-62.
6. Colao A, Pivonello R, Cavallo LM, Gaccione M, Auriemma RS, Esposito F, et al. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. Clin Endocrinol (Oxf). 2006;65(2):250-6.
7. Colao A, Amato G, Pedroncelli AM, Baldelli R, Grottoli S, Gasco V, et al. Genderand age-related differences in the endocrine parameters of acromegaly. J Endocrinol Invest. 2002;25(6):532-8.
8. Vierhapper H, Heinze G, Gessl A, Exner M, Bieglmayr C. Use of the oral glucose tolerance test to define remission in acromegaly. Metabolism. 2003;52(2):181-5.
9. Freda PU, Nuruzzaman AT, Reyes CM, Sundeen RE, Post KD. Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. J Clin Endocrinol Metab. 2004;89(2):495-500.
10. Rosário PW, Furtado MS. Growth hormone after oral glucose overload: revision of reference values in normal subjects. Arq Bras Endocrinol Metabol. 2008;52(7):1139-44.
11. Rosario PW. Measurement of basal GH in the diagnosis of acromegaly. Arq Bras Endocrinol Metabol. 2010;54(7):668-9.
12. Barkan AL, Beitins IZ, Kelch RP. Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab. 1988;67(1):69-73.
13. Dobrashian RD, O'Halloran DJ, Hunt A, Beardwell CG, Shalet SM. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Clin Endocrinol (Oxf). 1993;38(6):589-93.
14. Dimaraki EV, Jaffe CA, DeMott-Friberg R, Chandler WF, Barkan AL. Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. J Clin Endocrinol Metab. 2002;87(8):3537-42.
15. Brabant G, Von Zur Muhlen A, Wuster C, Ranke MB, Kratzsch J, Kiess W, et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res. 2003;60(2):53-60.
16. Elias PC, Lugao HB, Pereira MC, Machado HR, Castro M, Moreira AC. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity. Horm Metab Res. 2010;42(1):50-5.